xv 459 has been researched along with fibrinogen in 2 studies
| Studies (xv 459) | Trials (xv 459) | Recent Studies (post-2010) (xv 459) | Studies (fibrinogen) | Trials (fibrinogen) | Recent Studies (post-2010) (fibrinogen) |
|---|---|---|---|---|---|
| 15 | 2 | 0 | 34,477 | 1,707 | 7,083 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bozarth, J; DeGrado, W; Forsythe, M; Hussain, M; Kapil, R; Lorelli, W; Mousa, SA; Olson, RE; Reilly, TM; Sielecki, TM; Thoolen, MJ; Wexler, R; Wityak, J; Xue, CB | 1 |
| Bozarth, JM; Forsythe, MS; Friedman, PA; Lorelli, W; Mousa, SA; Reilly, TM; Slee, AM; Thoolen, MJ | 1 |
2 other study(ies) available for xv 459 and fibrinogen
| Article | Year |
|---|---|
Novel nonpeptide antiplatelet glycoprotein IIb/IIIa receptor antagonist, DMP754: receptor binding affinity and specificity.
Topics: Amino Acids; Animals; Cell Adhesion; Dogs; Fibrinogen; Guinea Pigs; Humans; Integrins; Isoxazoles; Mice; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Rabbits; Rats; Sensitivity and Specificity; Species Specificity | 1996 |
Antiplatelet efficacy of XV459, a novel nonpeptide platelet GPIIb/IIIa antagonist: comparative platelet binding profiles with c7E3.
Topics: Amino Acids; Animals; Antibodies, Monoclonal; Blood Platelets; Dogs; Fibrinogen; Humans; Isoxazoles; Papio; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex | 1998 |